Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Confidential contracting

- PMLiVE

AXON NAMES NEW PRESIDENT AND MANAGING PARTNER, TINA HAHN, AS RALPH SUTTON CHANGES LANE

April 30, 2025—Tina Hahn, who joined AXON in 2012 as Vice President, will now take on the role of AXON’s President and Managing Partner.

AXON

- PMLiVE

Eli Lilly and Creyon Bio enter oligonucleotide therapy partnership worth over $1bn

The companies will aim to develop RNA-targeted drugs for a broad range of diseases

- PMLiVE

AbbVie’s JAK inhibitor Rinvoq granted FDA approval to treat giant cell arteritis

The drug could allow patients to taper off steroids and achieve sustained remission

- PMLiVE

AstraZeneca’s Calquence regimens recommended by CHMP for chronic lymphocytic leukaemia

It is hoped that the fixed-duration treatments will reduce the risk of adverse events and drug resistance

- PMLiVE

Mastering pharma capability development cogs

The blueprint for success

- PMLiVE

Data visualization: translating complex data into emotive storytelling

By Ben Dean

Amiculum

Genesis Research Group A&P image

Strategy. Insights. Access. Genesis Research Group outlines its integrated, data-driven solutions for US and global access and pricing.

In today’s rapidly evolving environment, US and global access and pricing decisions demand robust evidence, rigorous analysis, and strategic precision. Following Genesis Research Group's recent expansion of its real-world data...

Genesis Research Group

regeneron headquarters

Regeneron’s bispecific antibody Lynozyfic approved by EC to treat multiple myeloma

More than 35,000 new cases of the blood cancer are diagnosed in Europe every year

- PMLiVE

MHRA approves Autolus Therapeutics’ Aucatzyl to treat acute lymphoblastic leukaemia

Approximately 765 new cases of the aggressive blood cancer are diagnosed in the UK every year

- PMLiVE

Takeda receives CHMP recommendation for Adcetris in Hodgkin lymphoma

The EC will review the committee’s positive opinion as it makes a decision on Adcetris in this indication

- PMLiVE

Client/agency partnerships – a marriage of science and creativity

The first step in the partnership is selecting the right agency

- PMLiVE

Five things to know when engaging Gen Z patients

Learn more about Gen Z: who they are, where they can be reached and how they like to be engaged and find Say’s five tips to consider when engaging with...

Say Communications

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links